Related Articles
Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis
Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer
Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors